Speaker Profile
Biography
She is a co-founder of enGenome and holds a Master's Degree in Biomedical Engineering, as well as a Ph.D. in Bioengineering and Bioinformatics. She is an expert in genomic data analysis and the development of bioinformatics tools. Currently, she serves as the Chief Science Officer at enGenome SRL, utilizing her extensive academic expertise to spearhead innovative projects and propel scientific progress within the organization. Her current focus is on harnessing generative AI technologies to enhance genomic data analysis.
Talk
Generative AI to Interpret Human Genomic Variations
In the fast-paced field of genomics, professionals struggle to keep up with vast, growing data. This challenge is critical in interpreting genomic variants, where timely, relevant literature is key. To aid this, VarChat (varchat.engenome.com) uses AI to condense scientific findings on genetic variants into clinically relevant summaries, linking to original sources for further research.
AI & Data Science Showcase:
EnGenome SRL
enGenome SRL is a cutting-edge bioinformatic company with the mission of enhancing healthcare with advanced genomics and AI.
EnGenome has developed the eVai platform, to enable precise and early diagnosis of Rare Disease ensuring unprecedented accuracy in interpreting genomic variants.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.